Merck Group Inaugurates State-of-the-Art Global Capability Centre in Bengaluru

Date:

Share post:

Merck Group has officially inaugurated its new, cutting-edge Global Capability Centre (GCC) in Electronic City, Bengaluru. Spanning an impressive 17,000 square metres, the integrated facility consolidates approximately 3,300 cross-functional professionals across data, digital, process, and technology functions under a single unified hub.

The state-of-the-art campus marks a significant expansion, positioning India as Merck’s fourth-largest global workforce hub, following Germany, the United States, and China. The facility houses the company’s largest concentration of Digital Enterprise Solutions capabilities. These specialized teams are tasked with designing, building, and executing enterprise-wide digital solutions that power global R&D, manufacturing, supply chains, and commercial operations across geographies.

“The Merck Global Capability Centre is much more than an operational hub; it is a strategic engine for our digital enterprise,” said Alessandro De Luca, Head of Digital Enterprise Solutions and Group CIO at Merck. “By bringing data, technology, and process teams under one roof, we are strengthening the foundation needed to scale innovation faster, improve agility, and deliver greater results.” The modern ecosystem features innovation labs, collaborative workspaces, and dedicated neurodiversity zones, building on Merck’s nearly six-decade legacy of presence in India.

Written by: Pragna Biswas

Graphics by: Pramit Hazra

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related articles

Bhawanipur Global Campus Announces iNATCONPH 2026: A Global Platform for Pharmacy & Allied Health Research

Kolkata: Bhawanipur Global Campus has announced the 16th International Conference - iNATCONPH 2026, a prestigious international scientific conference...

Emcure Pharma Receives CDSCO Approval to Launch Poviztra®️ for Fatty Liver Disease Treatment

Emcure Pharmaceuticals Ltd  announced that its co-marketed semaglutide brand, Poviztra®, has received regulatory approval from the Central Drugs...

CDSCO Partners with THSTI to Strengthen Vaccine and Healthcare innovation

The Central Drugs Standard Control Organization (CDSCO), India’s national regulatory authority, and the Translational Health Science and Technology...

EMeRG Launches Hospital Intel Suite™️ to transform MedTech Market

EMeRG, a leading healthcare intelligence provider with over a decade of industry expertise,  announced the launch of Hospital...